Form 4 for ELOX Eloxx Pharmaceuticals, Inc.
Accepted 2021-12-03 00:00:00 ET · period of report 2021-12-01 · accession 0001415889-21-005692 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-03 | 2021-12-01 | ELOX | MODUR VIJAY | HEAD OF R, D | F - Tax | $0.72 | -64.4K | 155.0K | -29% | -$46.3K |
| D | 2021-12-03 | 2021-12-01 | ELOX | MODUR VIJAY | HEAD OF R, D | M - OptEx | $0.00 | +219.3K | 219.3K | New | $0 |
| D | 2021-12-03 | 2021-12-01 | ELOX | MODUR VIJAY | HEAD OF R, D | M - OptEx | $0.00 | -219.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-01 | F | D | 64,373 | $0.72 | 154,953 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-01 | M | A | 219,326 | $0.00 | 219,326 | D | — | — | (F1) The restricted stock units issued to the reporting person on April 1, 2021 have fully vested and settled for shares of the Issuer's common stock. |
| 3 | Derivative | Restricted Stock Units | 2021-12-01 | M | D | 219,326 | $0.00 | 0 | D | — · — to — | 219,326 Common Stock | (F3) The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan. (F1) The restricted stock units issued to the reporting person on April 1, 2021 have fully vested and settled for shares of the Issuer's common stock. (F2) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |